Differences in socioeconomic status (SES) are known to be linked to differences in the risk of developing disease.
GLP-1 Agonists for Diabetes Tied to Lower Hyperkalemia Rates
Hyperkalemia in type 2 diabetes occurred less often with GLP-1 receptor agonists in routine care than dipeptidyl peptidase-4 (DPP-4) inhibitors, a large observational study in